Table 3.
Prevalence of CTC graded genitourinary (GU) toxicities at each follow-up to 36 months.
| Month | 1 | 3 | 6 | 9 | 12 | 18 | 24 | 30 | 36 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Toxicity | Grade | % | % | % | % | % | % | % | % | % |
| Hematuria | 0 | 97 | 98 | 96 | 97 | 95 | 92 | 94 | 95 | 93 |
| 1 | 3 | 2 | 4 | 3 | 5 | 6 | 5 | 3 | 1 | |
| 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | |
| 3 | 0 | 0 | 0 | 0 | 0 | 2 | 1 | 1 | 1 | |
| Dysuria | 0 | 88 | 91 | 91 | 91 | 86 | 95 | 93 | 92 | 93 |
| 1 | 12 | 9 | 9 | 9 | 12 | 5 | 6 | 7 | 7 | |
| 2 | 0 | 0 | 0 | 0 | 2 | 0 | 1 | 1 | 0 | |
| Incontinence | 0 | 77 | 85 | 86 | 80 | 82 | 83 | 79 | 68 | 77 |
| 1 | 21 | 13 | 14 | 18 | 16 | 16 | 21 | 29 | 19 | |
| 2 | 2 | 2 | 0 | 2 | 2 | 1 | 0 | 3 | 4 | |
| Urinary frequency/urgency | 0 | 53 | 58 | 73 | 71 | 69 | 69 | 70 | 51 | 51 |
| 1 | 45 | 41 | 27 | 28 | 28 | 30 | 29 | 50 | 49 | |
| 2 | 2 | 1 | 0 | 1 | 3 | 1 | 1 | 0 | 0 | |
| Retention | 0 | 62 | 69 | 71 | 66 | 71 | 67 | 62 | 56 | 59 |
| 1 | 23 | 23 | 18 | 23 | 16 | 20 | 23 | 34 | 32 | |
| 2 | 15 | 8 | 10 | 11 | 12 | 12 | 14 | 10 | 9 | |
| 3 | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | |
| Highest GU | 0 | 26 | 37 | 48 | 42 | 46 | 48 | 40 | 34 | 39 |
| 1 | 55 | 53 | 40 | 44 | 38 | 36 | 45 | 52 | 44 | |
| 2 | 18 | 10 | 10 | 15 | 16 | 14 | 14 | 12 | 16 | |
| 3 | 1 | 0 | 1 | 0 | 0 | 3 | 1 | 1 | 1 | |